Clinical trial for identifying the safety of the Ivermectin bath method. - The Ivermectin bath method

aboratory of medical safety management, Tokyo University of Science0 个研究点目标入组 6 人开始时间: 2012年9月27日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patient diagnosed with a skin disorder and thus has skin barrier problem 2) One who has had the experience of the following; - Hepatic disease - The disease considered to affect the test results by doctor in attendance. - The disease considered that use of Ivermectin results detrimental to the patient. 3) one with excessive consumption of caffeine contained coffee or drink (>8 cups / day) 4) abuser of medication or alcohol 5) The addict of an illegal drug 6) One who has contributed 200mL blood within 4 weeks before the trial, or male contributed 400mL blood within 12 weeks and female contributed 400mL blood within 16 weeks 7) One who participated in other clinical trials with the use of study medication within 4 weeks before the trial 8) One who has an anamnesis of hypersensitivity for the ingredients contained in Stromectol Tablets or in the baby bath powder (Pigeon, Inc.) 9) Pregnant female or lactating woman or child under 15kg weight 10) One whom the doctor considered to be unsuitable for this clinical trial

发起方

aboratory of medical safety management, Tokyo University of Science